Searchable abstracts of presentations at key conferences in endocrinology

ea0022p400 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Hepatic transplant and use of radionuclides as adyuvant therapies for patients with metastasic disease from neuroendocrine tumors

Del Olmo Maria Isabel , Argente Maria , Ramos Agustin , Camara Rosa , Navas Maria Soledad , Campos Vicente , Moya Angel , Merino-Torres Juan Francisco

Aim: Patients with malignant neuroendocrine tumors (mNETs) present frequently metastatic disease at diagnosis or during their follow-up. Hepatic transplant (HT) and radionuclide treatment have proved to be successful treatments. The aim of this report is to study the progression of the disease in patients with metastasic mNETs and HT.Patients and methods: Descriptive and retrospective study of patients diagnosed of metastasic mNETs and submitted to HT du...